The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
The Epidemiological Modelling of Major Depressive Disorder: Application for the Global Burden of Disease Study 2010
Open accessAbstract
BACKGROUND: Although the detrimental impact of major depressive disorder (MDD) at the individual level has been described, its global epidemiology remains unclear given limitations in the data. Here we present the modelled epidemiological profile of MDD dealing with heterogeneity in the data, enforcing internal consistency between epidemiological parameters and making estimates for world regions with no empirical data. These estimates were used to quantify the burden of MDD for the Global Burden of Disease Study 2010 (GBD 2010). METHOD: Analyses drew on data from our existing literature review of the epidemiology of MDD. DisMod-MR, the latest version of the generic disease modelling system redesigned as a Bayesian meta-regression tool, derived prevalence by age, year and sex for 21 regions. Prior epidemiological knowledge, study- and country-level covariates adjusted sub-optimal raw data. RESULTS: There were over 298 million cases of MDD globally at any point in time in 2010, with the highest proportion of cases occurring between 25 and 34 years. Global point prevalence was very similar across time (4.4% (95% uncertainty: 4.2-4.7%) in 1990, 4.4% (4.1-4.7%) in 2005 and 2010), but higher in females (5.5% (5.0-6.0%) compared to males (3.2% (3.0-3.6%) in 2010. Regions in conflict had higher prevalence than those with no conflict. The annual incidence of an episode of MDD followed a similar age and regional pattern to prevalence but was about one and a half times higher, consistent with an average duration of 37.7 weeks. CONCLUSION: We were able to integrate available data, including those from high quality surveys and sub-optimal studies, into a model adjusting for known methodological sources of heterogeneity. We were also able to estimate the epidemiology of MDD in regions with no available data. This informed GBD 2010 and the public health field, with a clearer understanding of the global distribution of MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This finding was driven by high prevalence estimates with 298 million MDD cases in 2010 [2] and 106 million cases of dysthymia [3].”
From Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease Study 2010 (2013) · cites this paper as [2]
In the citing paper
“GBD 2010's capacity to generate country-level burden as well as regional estimates was especially relevant for MDD, which has been linked to risk factors such as conflict [2],[37], intimate partner violence, and child sexual abuse [15], the levels of which vary between countries.”
From Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease Study 2010 (2013) · cites this paper as [2]
In the citing paper
“We found evidence for an elevated risk for mortality in those diagnosed with MDD [2],[25]; however, since a health outcome could only occur once in the GBD cause list, MDD related deaths from suicide and ischemic heart disease were captured under the headings of intentional injuries and cardiovascular disease in the GBD capstone papers [14],[18].”
From Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease Study 2010 (2013) · cites this paper as [2]
In the citing paper
“GBD 2010's capacity to generate country-level burden as well as regional estimates was especially relevant for MDD, which has been linked to risk factors such as conflict [2],[37], intimate partner violence, and child sexual abuse [15], the levels of which vary between countries.”
From Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease Study 2010 (2013) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citationLim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Self-citationMurray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Self-citationVos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Self-citationHow should meta‐regression analyses be undertaken and interpreted?
Thompson, S. G., & Higgins, J. P. T. (2002) · Statistics in Medicine · doi:10.1002/sim.1187 · Cited by 3,026 · cited 1×
“regression can be understood as an extension of a meta-analysis whereby data from different studies are pooled into a weighted average, adjusting for sources of variability between studies [51].”
BackgroundCross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302 · cited 2×
“8% [18] or between 2.”
BackgroundSteel, Z., Chey, T., Silove, D., Marnane, C., Bryant, R. A., & van Ommeren, M. (2009) · JAMA · doi:10.1001/jama.2009.1132 · Cited by 2,246 · cited 1×
“As described in previous work [57–60], conflict status is associated with an increase in the incidence (and therefore prevalence) of MDD.”
BackgroundCross-national epidemiology of DSM-IV major depressive episode
Bromet, E., Andrade, L. H., Hwang, I., Sampson, N. A., Alonso, J., de Girolamo, G., de Graaf, R., Demyttenaere, K., Hu, C., Iwata, N., et al. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-90 · Cited by 2,221
Global burden of depressive disorders in the year 2000
Üstün, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C., & Murray, C. J. L. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.5.386 · Cited by 1,735 · cited 1×
“In 2000, they were the 3 leading cause of burden as well as the leading cause of disability [6].”
Background
Flagged first, then by citations
Research works printed but not linked: 4
- Kessler RC, Ustun TB, editors(2008) The WHO World Mental Health Surveys: global perspectives on the epidemiology of mental disorders. New York: Cambridge University Press.
- Flaxman AD, Vos T, Murray CJL, editors(2013) An integrative metaregression framework for descriptive epidemiology. Washington: University of Washington Press, In press.
- 2007, World Population Prospects: The 2006 Revision, Highlights. Working Paper No. ESA/P/WP.202, Department of Economic and Social Affairs, Population Division
- J Angst, 2002, Gender differences in depression. Epidemiological findings from the European DEPRES I and II studies, Eur Arch Psychiatry Clin Neurosci, 252, 201
Cited by
Sorted by citations
Items 201–300 of 331
Impact of depression on speech perception in noise
Xie, Z., Zinszer, B. D., Riggs, M., Beevers, C. G., & Chandrasekaran, B. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220928 · Cited by 10
Vasileva, A. V. (2021) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2021-1-91-101 · Cited by 11
Wang, Q., Li, Y., Ren, H., Huang, Q., Wang, X., Zhou, Y., Wu, Q., Liu, Y., Li, M., Wang, Y., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.12.096 · Cited by 10
Jiménez, K. M., Pereira‐Morales, A. J., & Forero, D. A. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.02.050 · Cited by 11
Direct Discrepancy Dynamic Fit Index Cutoffs for Arbitrary Covariance Structure ModelsPreprint
McNeish, D., & Wolf, M. G. (2023) · doi:10.31234/osf.io/4r9fq · Cited by 10
Oppo, A., Forresi, B., Barbieri, A., & Koenen, K. C. (2024) · Journal of Traumatic Stress · doi:10.1002/jts.23090 · Cited by 9
Ahmadi, S., Hasani, A., Khabbaz, A., Poortahmasebi, V., Hosseini, S., Yasdchi, M., Mehdizadehfar, E., Mousavi, Z. B., Hasani, R., Nabizadeh, E., et al. (2024) · Biogerontology · doi:10.1007/s10522-024-10136-4 · Cited by 9
“Depressive disorders are usually characterized by long-term anhedonia in normal life activities for at least 15 days (Ferrari et al. 2013).”
Lee, T. (2025) · Cerebral Cortex · doi:10.1093/cercor/bhaf089 · Cited by 7
Miniati, M., Busia, S., Conversano, C., Orrù, G., Ciacchini, R., Cosentino, V., Marazziti, D., Gemignani, A., & Palagini, L. (2023) · Life · doi:10.3390/life13030803 · Cited by 12
Solem, C. T., Shelbaya, A., Wan, Y., Deshpande, C. G., Alvir, J. M., & Pappadopulos, E. A. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s115094 · Cited by 9
“7% of the population.(2) Lifetime prevalence estimates vary correspondence: caitlyn T solem Pharmerit international, real World evidence/Data analytics, 4350 east-West hwy, suite #430, Bethesda, MD 20814, Usa Tel +1 240 821 1267 Fax +1 240 821 1296 email csolem@pharmerit.”
Dipnall, J. F., Pasco, J. A., Berk, M., Williams, L. J., Dodd, S., Jacka, F. N., & Meyer, D. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417726860 · Cited by 10
Ye, X., Huang, J., Xia, L., Xu, X., Gong, X., & Xu, Y. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16071249 · Cited by 9
“Depressive disorders are the most common mental problems, occurring as early as at three years of age and across all world regions [5,6].”
BackgroundStructural gender inequalities and symptoms of postpartum depression in 40 countries
Martínez, P., Nazif‐Muñoz, J. I., Rojas, G., & Magaña, I. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.014 · Cited by 9
Scott, L. J. (2014) · CNS Drugs · doi:10.1007/s40263-014-0203-1 · Cited by 9
Tuergan, T., Abulaiti, A., Tulahong, A., Zhang, R., Shao, Y., & Aji, T. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.102810 · Cited by 8
Yankey, O., Amegbor, P. M., & Lee, J. (2021) · Spatial and Spatio-temporal Epidemiology · doi:10.1016/j.sste.2021.100438 · Cited by 8
Ceolato, C., Chevallier‐Collins, C., Clément, J., Charles, E., Lacroix, A., & Ranoux, D. (2024) · Depression and Anxiety · doi:10.1155/2024/1177925 · Cited by 7
Charlson, F., Lee, Y. Y., Diminic, S., & Whiteford, H. (2016) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2016.4 · Cited by 7
“…and PTSD. DisMod-MR, a Bayesian meta-regression tool designed specifically for GBD 2010, was used to develop predictive estimates of age-specific prevalence in conflict-affected populations, whilst simultaneously adjusting estimates for heterogeneity between studies (Ferrari et al. 2013a, b).”
MethodSelf-citationWang, H., Frasco, E., Shang, J., Chen, M., Xin, T., & Tang, K. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-048554 · Cited by 7
Escamilla-Orozco, R. I., González-Trujano, M. E., Mariscal, J. M. G., Torres-Valencia, J. M., Guzmán-González, H., Vega, J. L., & Loizaga-Velder, A. K. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2246459 · Cited by 7
“More than 300 million people worldwide suffer from depression, representing about 4.4% of the world’s population (Ferrari et al. 2013).”
BackgroundInfluentialSarrouilhe, D., & Dejean, C. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.07.002 · Cited by 7
Charlson, F., Diminic, S., Choulamany, C., Santomauro, D. F., Raja, S., & Whiteford, H. (2017) · Epidemiology and Psychiatric Sciences · doi:10.1017/s204579601700035x · Cited by 7
“It has been noted elsewhere that reported prevalence rates of MDD in Asian countries are typically lower than many other regions of the world (Bromet et al. 2011; Ferrari et al. 2013).”
BackgroundSelf-citationAudhoe, S. S., Hoving, J. L., Zijlstra, B. J. H., Frings‐Dresen, M. H. W., & Nieuwenhuijsen, K. (2021) · BMC Public Health · doi:10.1186/s12889-021-10704-0 · Cited by 7
Community mental health interventions for people with major depressive disorder: A scoping review
Tan, R. X. R., & Goh, Y. S. (2022) · International Journal of Mental Health Nursing · doi:10.1111/inm.13029 · Cited by 11
The role of psychotherapy as a medical specialty in public health
Незнанов, Н. Г., Vasilyeva, A. V., & Salagay, O. О. (2022) · Public Health · doi:10.21045/2782-1676-2022-2-2-40-57 · Cited by 11
Lam, R. W., Rnic, K., Nunez, J.-J., Ho, K., LeMoult, J., Nunes, A., Chakrabarty, T., Foster, J. A., Frey, B. N., Harkness, K. L., et al. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251337603 · Cited by 6
Ward, E. J., Hawrilenko, M., Brown, M. D., & Chekroud, A. M. (2025) · Online Journal of Public Health Informatics · doi:10.2196/72999 · Cited by 7
“Depression and anxiety affect over 280 million people worldwide [1,2], with over 9% of Americans having depression and 18% having anxiety [3].”
Guo, J., Wang, L., Zhao, X., Wang, D., & Zhang, X. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.02.026 · Cited by 10
Gao, W., Deng, Z., Cai, X., Zhang, D., Han, X., & Zhang, X. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05574-w · Cited by 7
“Major depressive disorder (MDD) is characterized by persistent low mood, decreased interest in most activities, weight loss, difficulty sleeping and concentrating [1].”
BackgroundBaldwin, D. S., Adair, M., Micheelsen, A., Åström, D. O., & Reines, E. H. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2313108 · Cited by 6
Yoon, H. S., Hattori, K., Sasayama, D., & Kunugi, H. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.039 · Cited by 6
Peng, Q., Shi, L., Kong, Y., Yan, Y. C., Zhan, J., Wen, Y., Liu, W., De-xian, Y., Zhou, Z., & Yan, H. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146801 · Cited by 6
Mondelli, V., Cattaneo, A., Nikkheslat, N., Souza, L., Walsh, A. E. L., Zajkowska, Z., Zonca, V., Marizzoni, M., Fisher, H. L., Kohrt, B. A., et al. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100396 · Cited by 6
Anxiety, Depression, and Smoking Status Among Adults of Mexican Heritage on the Texas-Mexico Border
Wilkinson, A. V., Vatcheva, K. P., Pérez, A., Reininger, B. M., McCormick, J. B., & Fisher‐Hoch, S. P. (2014) · Hispanic Journal of Behavioral Sciences · doi:10.1177/0739986314540455 · Cited by 6
“Overall, and across the life span, women report greater levels of anxiety (Kessler et al., 2010) and depression (Ferrari et al., 2013) than men, which was also the case in our study.”
Civardi, S. C., Besana, F., Miacca, G. C., Mazzoni, F., Arienti, V., Politi, P., Brondino, N., & Olivola, M. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1371139 · Cited by 9
Response trajectories during escitalopram treatment of patients with major depressive disorder
Nuñez, J.-J., Liu, Y. S., Cao, B., Frey, B. N., Ho, K. T., Milev, R. V., Müller, D. J., Rotzinger, S., Soares, C. N., Taylor, V. H., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115361 · Cited by 5
Kengganpanich, M., Pengpid, S., & Peltzer, K. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-071980 · Cited by 5
Eli, K. (2018) · International Journal of Eating Disorders · doi:10.1002/eat.22969 · Cited by 8
Buru, T. H., Kállay, É., Olar, L. E., Ştefan, R., Cantor, M. E., Papuc, I., & Buta, E. (2021) · Acta Horticulturae · doi:10.17660/actahortic.2021.1330.10 · Cited by 5
Ma, R., Luo, Y., Liu, S., Wang, X., Guo, H., Zhao, M., Chen, N., Liu, P., Shi, J., Li, Y., et al. (2023) · Brain and Behavior · doi:10.1002/brb3.3047 · Cited by 4
Shiozawa, A., Hopson, S. D., Fuldeore, R. M., Stoelzel, M., Ng, D., & Hairston, J. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01485-w · Cited by 5
“It occurs most often in young adults 25–34 years of age and more frequently in women than men [4].”
BackgroundDepression literacy in women attending university hospital clinics in Riyadh Saudi Arabia
Siddiqui, A. R., Mahasin, S., Alsajjan, R., Hassounah, M. M., Alhalees, Z., Alsaif, N. K., Alosaimi, F. D., & Alquaiz, A. M. (2017) · International Journal of Social Psychiatry · doi:10.1177/0020764016685346 · Cited by 5
Wang, Y., Li, Y., Ji, Z., Han, F. L., Yang, D., & Lv, C. (2021) · Sustainability · doi:10.3390/su14010059 · Cited by 4
Tracking depressed mood using speech pause patterns
Wolters, M. K., Ferrini, L., Farrow, E., Tâtar, A. S., & Burton, C. D. (2015) · Edinburgh Research Explorer (University of Edinburgh) · Cited by 4
Wu, T., Dong, S., Yang, L., Qiu, H. X., Qiu, H. X., Mellor, D. J., Chen, J., & Xu, Y. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1089504 · Cited by 3
“Specifically, a change (step) was identified if there was a (1) Switch: The patient AD medication(s) was changed by initiating one or more different AD(s) and discontinuing the prior AD(s) within a 30-day period, the new AD(s) must have a minimum supply of 30 days, and (2) Add-on: The patient’s treatment regimen was m…”
BackgroundMethodLv, Z., & Deng, C. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.06.028 · Cited by 4
Depression-related innate immune genes and pan-cancer gene analysis and validation
Yang, Y., Han, W., Zhang, X., Yuan, H., Wang, R., Yang, J. Y., An, C., & Huang, D. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2024.1521238 · Cited by 4
Ismail, A., Jaalouk, K., Kotaich, J., Tarhini, Y., Sadier, N. S., & Abbas, L. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-07076-5 · Cited by 3
Riecher‐Rössler, A. (2019) · Mental health and illness worldwide · doi:10.1007/978-981-10-0371-4_9-1 · Cited by 3
Nwabueze, C., Elom, H., Liu, S. Z., Walter, S. M., Sha, Z., Acevedo, P., Ying Liu, Su, B., Xu, C. D., Piamjariyakul, U., et al. (2021) · Journal of Addictive Diseases · doi:10.1080/10550887.2021.1957639 · Cited by 3
Sex and Gender Differences in Psychosocial Risk Factors for Ischemic Heart Disease
Mommersteeg, P. M. C., Widdershoven, J. W. M. G., & Kop, W. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-54960-6_13 · Cited by 3
Gabbay, M., Shiels, C., & Hillage, J. (2017) · Journal of Mental Health · doi:10.1080/09638237.2017.1340620 · Cited by 3
Martínez, P., Castro, A., Alonso, D., Vöhringer, P. A., & Rojas, G. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-011249 · Cited by 4
Rückkehr an den Arbeitsplatz von Beschäftigten nach einer psychischen Erkrankung
Scharf, J., Loerbroks, A., & Angerer, P. (2022) · Zentralblatt für Arbeitsmedizin Arbeitsschutz und Ergonomie · doi:10.1007/s40664-022-00471-z · Cited by 2
Hamdan, A., Ghzayel, L., Semaan, Z. M., Hosn, O. A., Daou, A. M., Chaar, J. A., Nawfal, N., & Barazi, R. (2025) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.70256 · Cited by 2
Troppoli, T. A., & Thompson, S. M. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.10.036 · Cited by 3
Tu, J., Yi, T.-P., & Tu, M.-Q. (2025) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174251410075 · Cited by 2
Berg, N., Piirtola, M., Marttunen, M., Latvala, A., & Kiviruusu, O. H. (2026) · Nordic Studies on Alcohol and Drugs · doi:10.1177/14550725251408211 · Cited by 3
“The prevalence follows a similar pattern in Western countries, though trends vary globally (Ferrari et al., 2013; Kessler & Bromet, 2013).”
Kaczmarek, E. S., Rodrigues, N. B., Chisamore, N., Doyle, Z., Meshkat, S., Blainey, M. G., Brudner, R. M., Ali, S., Teopiz, K. M., McIntyre, R. S., et al. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121385 · Cited by 3
Nepton, A., Farahani, H., Williams, M. T., Booij, L., & Faber, S. C. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00343 · Cited by 2
Wang, Z., & Teng, X. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119689 · Cited by 2
A Serum Analysis before and after Antidepressant Treatment in Major Depression: A Pilot Study
Girard, M. F., Vuillier-Devillers, K., Pinault, É., Bessette, B., Plansont, B., & Malauzat, D. (2015) · Clinical Medicine Insights Psychiatry · doi:10.4137/cmpsy.s20765 · Cited by 2
Kop, W. J., & Mommersteeg, P. M. C. (2014) · Springer eBooks · doi:10.1007/978-3-319-09241-6_9 · Cited by 2
Stéphan, F., Galudec, M. L., Tritschler-LeMaître, M.-H., Berrouiguet, S., & Walter, M. (2014) · Journal de Thérapie Comportementale et Cognitive · doi:10.1016/j.jtcc.2014.05.002 · Cited by 2
Lee, I. N., Huang, T. L., Huang, Y. L., Hung, Y. Y., & Kang, H. Y. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000385 · Cited by 2
Long-term effect of a care manager on work ability for patients with depression – the PRIM-CARE RCT
Petersson, E., Hange, D., Udo, C., Björkelund, C., & Svenningsson, I. (2022) · Work · doi:10.3233/wor-205272 · Cited by 2
“According to WHO, more than 300 million people in the world are affected with depression [6].”
Pengpid, S., & Peltzer, K. (2023) · Elderly Health Journal · doi:10.18502/ehj.v9i2.14424 · Cited by 2
Dienhart, C., Aigner, E. S., Iglseder, B., Frey, V., Gostner, I., Langthaler, P. B., Paulweber, B., Trinka, E., & Wernly, B. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13154492 · Cited by 2
“Screening tools, such as the BDI, tend to overestimate the presence of mental illness [61].”
MethodFaisal‐Cury, A., Tabb, K. M., Maruyama, J. M., & Matijasevich, A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1029048 · Cited by 1
“Gender differences exists where SI and depression are 2–3 times higher in women in comparison with men (4, 5).”
BackgroundThe burden of depression among women of childbearing age globally from 1990 to 2019
Wang, Y., Jiang, Q., Shu, P., & Xu, J. (2025) · Archives of Medical Science · doi:10.5114/aoms/208221 · Cited by 1
“With the current global focus on mental health issues, it is crucial to stay informed about the trends in depression incidence rates to inform public health policies and medical services effectively [11].”
EEG ANALYSIS OF MUSIC GENRES AND THEIR EFFECTS ON DEPRESSION RELIEF
Chiang, H., Hsu, W.-C., & Chou, Y.-H. (2026) · Journal of Mechanics in Medicine and Biology · doi:10.1142/s021951942640052x · Cited by 2
Qin, K., & Wei, Q. (2026) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-026-02265-3 · Cited by 3
“Existing comparative studies predominantly focus on diagnostic criteri [12], epidemiological characteristic [13], and gender differences in disability-adjusted life years (DALYs) [14].”
Burden of chronic kidney disease due to type 2 diabetes mellitus in Asia: A retrospective analysis
Shahab, S. H., Javaid, M. H., Masood, H. G., Maheshwari, S., Ahmed, M. A. A., Zahid, M., Naqvi, S. M., Hassan, A., & Habib, F. (2026) · Medicine · doi:10.1097/md.0000000000049403 · Cited by 1
“[9] The estimates of all uncertainties were based on 1000 posterior draws, which produced 95% uncertainty intervals (UI) to take into consideration variations in data inputs, model assumptions, and sampling errors.”
Concilio, C. (2018) · Aging studies · doi:10.14361/9783839444269 · Cited by 1
Prevalence of depression and factors associated with Brazilian workers
Haeffner, R., & Santana, L. D. L. (2019) · International Journal of Family & Community Medicine · doi:10.15406/ijfcm.2019.03.00173 · Cited by 1
Khademi, A., Kamyab, P., Kouchaki, H., Kazemi, M., & Goharinia, M. (2025) · BMC Public Health · doi:10.1186/s12889-025-22993-w · Cited by 1
“Furthermore, the Global Burden of Disease Study indicates that major depression occurs more frequently in females compared to males (5 · 5% of women versus 3 · 2% of men) [9].”
Jörgensen, S. K. M., Surridge-Smith, M., Jones, K. M., Maletı́nská, L., Allen, N. D., & Petřík, D. (2025) · PLoS ONE · doi:10.1371/journal.pone.0329268 · Cited by 1
“It increases the risk of Type 2 diabetes [1], cardiovascular diseases [2], or cancer [3,4] and it is the second leading cause of disability [5], resulting in a massive economic impact of pandemic proportions [6,7].”
Uka, F., Zharku, L., Maliqi, R., Habibi, M., Podrimqaku, D., Musliu, A., Acik, A. N., Loshenko, O., Morales, R. F., Sopjani, V., et al. (2025) · BMC Psychology · doi:10.1186/s40359-025-03512-3 · Cited by 2
“Globally, MDD affects approximately 280 million people, with 10–20% of adolescents experiencing mental health conditions annually [24, 25].”
Scott, L. J. (2017) · Drugs & Therapy Perspectives · doi:10.1007/s40267-017-0439-1 · Cited by 1
Нейрометаболічна стратегія фармакотерапії афективних розладів: кому, коли і навіщо?
С.Г., Б. (2021) · Український медичний часопис · doi:10.32471/umj.1680-3051.141.198273 · Cited by 1
Basar, M. A., Hosen, M. F., Amin, M. A., Bithi, N. I., & Paul, B. K. (2022) · IEEE International Women in Engineering (WIE) Conference on Electrical and Computer Engineering (WIECON-ECE) · doi:10.1109/wiecon-ece57977.2022.10151170 · Cited by 1
“The chemical imbalance that causes major depressive disorder (MDD) is a major contributor to global disease burden [3].”
BackgroundBerg, N., Piirtola, M., MARTTUNEN, M. J., Latvala, A., & Kiviruusu, O. H. (2024) · medRxiv · doi:10.1101/2024.03.06.24303863 · Cited by 1
“…studies have quite consistently shown that the prevalence of depression increases from childhood to young adulthood, and in Western countries decreases after young adulthood, but there are differing views on whether the prevalence decreases or stabilizes/increases in other regions (16,17).”
BackgroundSaymah, D.-E. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
Jovicic, M. J., Radovanovic, S. M., Marić, N. P., & Kostić, V. (2014) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh1406280j
Tratamento medicamentoso da depressão maior refratária
Rocha, F. L., Hara, C., & Barbosa, I. G. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Onko masennus lisääntynyt suomalaisessa aikuisväestössä?
Markkula, N., & Suvisaari, J. (2018) · Sosiaalilääketieteellinen Aikakauslehti · doi:10.23990/sa.74420 · Cited by 9
Thiruchselvam, T. (2018) · TSpace (University of Toronto)
Frequency of depression in patients with Type 1 and Type 2 diabetes mellitus.
Nawaz, Z., Afridi, A., Asif, S., Nizami, A. T., & Minhas, F. A. (2020) · The Professional Medical Journal · doi:10.29309/tpmj/2020.27.06.4565
Jia, S., Song, X., Wang, L., & Shao, X. (2020) · Psychiatric Quarterly · doi:10.1007/s11126-020-09795-6
Tumaini, W. J., Njiru, L., & Kitonga, D. M. (2020) · The International Journal of Humanities & Social Studies · doi:10.24940/theijhss/2020/v8/i2/hs2002-081
Peng, Q., Kong, Y., Shi, L., Yan, Y. C., Yao, Y., Wen, Y., Liang, Y.-M., Lai, C., Deng, Z., & Yan, H. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135361
Patterns of Antidepressant Prescriptions for the Treatment of Depression: A Scoping ReviewPreprint
Marasine, N. R., Sankhi, S., Lamichhane, R., & Dangi, N. B. (2020) · doi:10.21203/rs.3.rs-65197/v1
Favaro, E. (2018) · transcript Verlag eBooks · doi:10.1515/9783839444269-012
(2018) · transcript Verlag eBooks · doi:10.1515/9783839444269
Elevada prevalência de depressão em pacientes de um ambulatório de referência em fibromialgia
Tonoli, S. G., de Oliveira, A. J. C. N., Henna, A. J., Martinez, J. E., & Henna, E. (2022) · Debates em Psiquiatria · doi:10.25118/2763-9037.2022.v12.222
PhD Studies Hurt Mental Health, but Less than You ThinkPreprint
Keloharju, M., Knüpfer, S., Müller, D., & Tå̊g, J. (2022) · Research Square · doi:10.21203/rs.3.rs-2057354/v1
Депресія, тривога і порушення сну: як вийти із замкненого кола
Burchynskyi, S. H. (2022) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.18.3.2022.950
de Souza, L. B. T., de Souza, S. T., Vieira, S. E., dos Santos, W. G., Loures, S. L. D. C. D. S., Nunes, B. M., dos Reis, R. H., Brinati, L. M., Cheloni, I. G., Souza, W. M. S., et al. (2022) · doi:10.22533/at.ed.0442217109
A SUPLEMENTAÇÃO COM SELÊNIO COMO TRATAMENTO COADJUVANTE EM PACIENTES COM TIREOIDITE DE HASHIMOTO
da Silva, J. L., Pontes, T. C. D. S., & Nascimento, V. S. D. V. (2022) · doi:10.22533/at.ed.0442217108
ELEVADA PREVALÊNCIA DE DEPRESSÃO EM PACIENTES DE UM AMBULATÓRIO DE REFERÊNCIA EM FIBROMIALGIA
Tonoli, S. G., de Oliveira, A. J. C. N., Henna, A. J., & Henna, E. (2022) · doi:10.22533/at.ed.04422171013
Metadata
- Authors
- Ferrari, A. J., Charlson, F. J., Norman, R. E., Flaxman, A. D., Patten, S. B., Vos, T., & Whiteford, H. A.
- Affiliations
- The University of Queensland (AU)
- University of Washington (US)
- University of Calgary (CA)
- Corresponding author
- Ferrari, Alize J.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-29
- Volume
- 8
- Issue
- 7
- Pages
- e69637
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3726670
- OpenAlex
- W1504574652
- Cited by
- 330
- References
- 58
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 27 · 2023: 20 · 2022: 38 · 2021: 32 · 2020: 25 · 2019: 30 · 2018: 25 · 2017: 28 · 2016: 24 · 2015: 20 · 2014: 19 · 2013: 5
- FWCI
- 33.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Faculty of Health; Institute of Health and Biomedical Innovation
- Funders
- Bill and Melinda Gates Foundation
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- major depressive disorder, global burden of disease, disease prevalence, incidence, depression duration, sex differences, conflict zones, age distribution, Bayesian meta-regression, global epidemiology
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Major Depressive Disorder, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Models, Theoretical, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
